| Yelena Faynzilbert, DO | |
|
27351 Dequindre Rd, Madison Hts, MI 48071-3487 | |
| (248) 967-7795 | |
| (248) 967-7794 |
| Full Name | Yelena Faynzilbert |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 27351 Dequindre Rd, Madison Hts, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063670750 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 5101017608 (Michigan) | Primary |
| Entity Name | Ny Priority Medical Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144506056 PECOS PAC ID: 1759542582 Enrollment ID: O20120423000068 |
News Archive
Health Evolution Partners and Verizon Enterprise Solutions have established a strategic relationship to encourage innovation and adoption of connected health information technologies that help drive patient care improvements and better manage costs.
Ontario is investing $25 million over five years to support new treatments and therapies for people living with chronic diseases, such as cancer, multiple sclerosis and diabetes.
Bristol-Myers Squibb Company announced today the pricing terms of its previously announced cash tender offer for up to $750 million aggregate principal amount of certain of its outstanding debt securities.
Scientists have developed new drug compounds that thwart the pro-cancer activity of FOXM1, a transcription factor that regulates the activity of dozens of genes.
› Verified 4 days ago
| Entity Name | Yelena Faynzilbert Do Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245667930 PECOS PAC ID: 9436381654 Enrollment ID: O20140422000841 |
News Archive
Health Evolution Partners and Verizon Enterprise Solutions have established a strategic relationship to encourage innovation and adoption of connected health information technologies that help drive patient care improvements and better manage costs.
Ontario is investing $25 million over five years to support new treatments and therapies for people living with chronic diseases, such as cancer, multiple sclerosis and diabetes.
Bristol-Myers Squibb Company announced today the pricing terms of its previously announced cash tender offer for up to $750 million aggregate principal amount of certain of its outstanding debt securities.
Scientists have developed new drug compounds that thwart the pro-cancer activity of FOXM1, a transcription factor that regulates the activity of dozens of genes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yelena Faynzilbert, DO 27351 Dequindre Rd, Madison Hts, MI 48071-3487 Ph: (248) 967-7795 | Yelena Faynzilbert, DO 27351 Dequindre Rd, Madison Hts, MI 48071-3487 Ph: (248) 967-7795 |
News Archive
Health Evolution Partners and Verizon Enterprise Solutions have established a strategic relationship to encourage innovation and adoption of connected health information technologies that help drive patient care improvements and better manage costs.
Ontario is investing $25 million over five years to support new treatments and therapies for people living with chronic diseases, such as cancer, multiple sclerosis and diabetes.
Bristol-Myers Squibb Company announced today the pricing terms of its previously announced cash tender offer for up to $750 million aggregate principal amount of certain of its outstanding debt securities.
Scientists have developed new drug compounds that thwart the pro-cancer activity of FOXM1, a transcription factor that regulates the activity of dozens of genes.
› Verified 4 days ago